Engineered exosomes reprogram Gli1
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
21 07 2023
21 07 2023
Historique:
medline:
24
7
2023
pubmed:
21
7
2023
entrez:
21
7
2023
Statut:
ppublish
Résumé
Calcification of autologous pathological vessels and tissue engineering blood vessels (TEBVs) is a thorny problem in clinic. However, there is no effective and noninvasive treatment that is available against the calcification of TEBVs and autologous pathological vessels. Gli1
Identifiants
pubmed: 37478186
doi: 10.1126/sciadv.adf7858
pmc: PMC10361604
doi:
Substances chimiques
Zinc Finger Protein GLI1
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eadf7858Références
Circ Res. 2018 May 25;122(11):1608-1624
pubmed: 29798903
Circulation. 2021 Apr 6;143(14):1426-1449
pubmed: 33819075
Circ Res. 2011 Sep 2;109(6):697-711
pubmed: 21885837
Pharmacol Ther. 2017 Mar;171:65-74
pubmed: 27595928
Diabetes Care. 2015 Oct;38(10):1937-44
pubmed: 26253729
Cell Stem Cell. 2015 Jan 8;16(1):51-66
pubmed: 25465115
J Am Coll Cardiol. 2019 Nov 19;74(20):2529-2532
pubmed: 31727292
Cardiovasc Res. 2018 Mar 15;114(4):590-600
pubmed: 29514202
Biomaterials. 2014 Dec;35(36):9608-19
pubmed: 25176065
Aging (Albany NY). 2020 Nov 6;12(21):21220-21235
pubmed: 33159018
Circ Res. 2022 Jun 24;131(1):109-126
pubmed: 35737757
J Cell Physiol. 2020 Feb;235(2):706-717
pubmed: 31254289
Chem Biol Interact. 2021 Sep 25;347:109617
pubmed: 34391751
J Am Coll Cardiol. 2021 Sep 14;78(11):1145-1165
pubmed: 34503684
Macromol Biosci. 2018 Feb;18(2):
pubmed: 29205878
Bioact Mater. 2021 Jun 25;7:466-477
pubmed: 34466746
Trends Mol Med. 2019 Dec;25(12):1133-1146
pubmed: 31522956
Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F275-F285
pubmed: 31116605
Cell Stem Cell. 2014 Feb 6;14(2):160-73
pubmed: 24506883
Mol Cell Biochem. 2021 May;476(5):2193-2201
pubmed: 33559827
Circulation. 2013 Oct 29;128(18):2047-57
pubmed: 24077167
J Clin Invest. 2008 Feb;118(2):515-25
pubmed: 18188448
Cell Rep. 2019 Jul 30;28(5):1346-1361.e4
pubmed: 31365875
Biomaterials. 2019 Jun;204:13-24
pubmed: 30875515
Circulation. 2019 Jul 9;140(2):147-163
pubmed: 31146585
Stem Cell Reports. 2020 Jul 14;15(1):110-124
pubmed: 32668219
Free Radic Biol Med. 2021 Aug 1;171:55-68
pubmed: 33974977
Dev Biol. 2018 Mar 1;435(1):41-55
pubmed: 29331499
Cell Stem Cell. 2016 Nov 3;19(5):628-642
pubmed: 27618218
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):938-47
pubmed: 25722432
Yonsei Med J. 2019 Aug;60(8):751-759
pubmed: 31347330
Nat Nanotechnol. 2021 Jul;16(7):748-759
pubmed: 34211166
Cardiovasc Pathol. 2011 Jul-Aug;20(4):213-21
pubmed: 20619685
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1465-1478
pubmed: 31395217
JACC Cardiovasc Imaging. 2018 Jan;11(1):127-142
pubmed: 29301708
Biochem Biophys Res Commun. 2013 Mar 22;432(4):612-7
pubmed: 23438432
Pharmacol Res. 2020 Aug;158:104861
pubmed: 32407954
Cell Rep. 2022 Jun 21;39(12):110981
pubmed: 35732119
Cell Stem Cell. 2020 Apr 2;26(4):542-557.e11
pubmed: 32243809
Mol Med Rep. 2012 Aug;6(2):287-92
pubmed: 22613963
Nucleic Acids Res. 2021 Jul 2;49(W1):W317-W325
pubmed: 34086934
Biomaterials. 2017 Nov;144:166-175
pubmed: 28841463